Pfizer Inc
Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%
Pfizer Premarin Family [legacy through FY24] by Year
Premarin Family (conjugated estrogens) [legacy through FY24] — Worldwide reported YoY (%) (%)
Pfizer Premarin Family [legacy through FY24]: -4.0% in FY2024, down 12.0 pts from a year earlier. No newer figure appears in the documents we track.
Where the FY2024 figure comes from
“|| Premarin family | 380 | 397 | (4%) | (4%) | 341 | 361 | (5%) | 39 | 36 | 8% | 9%”
Source: Form 8-K (Earnings / Guidance Release) (pfe-12312024xex99.htm, filed 2025-02-04) ↗
Reported in Form 8-K Revenue Tables.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Pfizer Premarin Family [legacy through FY24] (%), annual FY2017–FY2024 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/premarin-leg-yoy-ww
See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.